Written by Charlie Zei, Senior Vice President of Enterprise Strategy and Government Programs at WellRight. Charlie leads WellRight's Government Healthcare Partnerships team and chairs the Government Affairs Committee at the Population Health Alliance.
The commentary on LEAD has been thorough on the parts the ACO industry already knows how to talk about. Risk mechanics, benchmark structure, whole-TIN participation, and financial guarantees are all guaranteed spots at the conversational round table, while topics like the Beneficiary Engagement Incentives have received a fraction of the same attention.
Buried in the LEAD RFA is a Beneficiary Engagement Incentive called the Chronic Disease Prevention Reward. Its mechanics are simple; ACOs may offer healthy food products to beneficiaries who engage in healthy-living activities and participate in evidence-based prevention or management programs. Everything is ACO-funded and safe-harbor protected under the existing framework for CMS-sponsored model patient incentives, with implementation plans being submitted directly to CMS.
The description may seem clear enough, but the build behind it is a little more involved.
The Implementation Period runs from September 15 through December 31, 2026. In that window, accepted ACOs must finalize care model design, stand up data pipelines with CMS, complete key hires, and submit implementation plans for each BEI and Benefit Enhancement they intend to adopt.
For ACOs opting into the Chronic Disease Prevention Reward, that window is when the underlying infrastructure gets built or bought. And three and a half months is not a lot of runway for either.
The Strategic Question Worth Naming
Two internal conversations are worth having before the Implementation Period kickoff:
-
The first is which BEIs and Benefit Enhancements an organization will adopt. The Chronic Disease Prevention Reward has the most direct connection to healthy living outcomes among the BEIs. The Medical Nutrition Therapy expansion extends coverage to a broader range of diet-sensitive chronic conditions. The Part D Premium Buydown becomes available in 2029.
-
The second is a build-versus-buy question. Framed narrowly, it becomes a hiring question; does the organization staff up to build engagement-and-rewards capability internally, or does it partner with a vendor? Framed correctly, it becomes something more useful; is engagement-and-rewards a category in which this organization has genuine institutional expertise, or one better addressed through a partnership with an organization that already operates in it?
Neither answer is inherently correct. The narrow framing tends to produce default answers, while the correct framing produces better ones.
WellRight is a digital wellness, engagement, and rewards platform. We came up on the commercial wellness side and have invested the time adapting our platform for government healthcare populations: Medicare Advantage, Medicaid Managed Care Organizations, and ACOs.
WellRight's platform capabilities align most directly with the operational requirements of the Chronic Disease Prevention Reward. Incentive program design, multi-channel engagement across Medicare beneficiary populations, reward fulfillment and documentation, and CMS-cadence reporting can be fully accessed and tailored based on evolving needs.
The scope has clear limits, which is part of what makes the fit credible. WellRight is not a risk-bearing entity, an EHR, or a Medical Nutrition Therapy provider. We do not replace an ACO's clinical workflows or care management functions; we are a partner to the engagement, rewards, and reporting layer of a LEAD ACO.
If LEAD is on Your Organization's Roadmap
WellRight welcomes conversations with ACO leadership evaluating engagement-and-rewards infrastructure for the Implementation Period.
.png)
